Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
2.
Anesth Analg ; 101(1): 2-8, table of contents, 2005 Jul.
Article in English | MEDLINE | ID: mdl-15976197

ABSTRACT

We hypothesized that mitral regurgitation (MR) would be exacerbated, cardiac index (CI) decreased, and mean pulmonary artery pressure (MPAP) increased in patients with coexisting MR during off-pump coronary artery bypass (OPCAB) anastomosis, and that milrinone could ameliorate increases in MR that occur during OPCAB anastomosis. Subjects comprised 140 patients scheduled for elective OPCAB divided into three groups: patients without MR (MR(-) group; n = 57), patients with MR (MR(+) group; n = 41), and patients with MR who received milrinone (M+MR(+) group; n = 42). Patients with grade 1+ or 2+ MR were included, whereas those with grade 3+ or 4+ MR were excluded. Hemodynamic variables were measured after the induction of anesthesia and during anastomosis. IV infusion of milrinone (0.5 microg . kg(-1) . min(-1)) started immediately after the induction of anesthesia in the M+MR(+) group. CI was significantly decreased (P < 0.0001), and MPAP and MR were significantly increased (P < 0.001) during left coronary anastomosis in the MR(+) group compared with the MR(-) group. CI was significantly higher (P < 0.001), and neither MPAP nor MR were increased (P < 0.05) during left coronary artery anastomosis in the M+MR(+) group compared to the MR(+) group. In patients with MR, anastomosis of the left coronary artery branches was associated with decreased CI and increased regurgitation and MPAP. In such patients, treatment with milrinone helps to stabilize hemodynamics during anastomosis.


Subject(s)
Cardiotonic Agents/therapeutic use , Coronary Artery Bypass, Off-Pump , Hemodynamics/drug effects , Hemodynamics/physiology , Milrinone/therapeutic use , Mitral Valve Insufficiency/drug therapy , Mitral Valve Insufficiency/physiopathology , Vasodilator Agents/therapeutic use , Adrenergic alpha-Agonists/administration & dosage , Adrenergic alpha-Agonists/therapeutic use , Aged , Anesthesia , Cardiac Output/drug effects , Dopamine/administration & dosage , Dopamine/therapeutic use , Double-Blind Method , Female , Humans , Male , Middle Aged , Monitoring, Intraoperative , Norepinephrine/administration & dosage , Norepinephrine/therapeutic use , Pacemaker, Artificial
SELECTION OF CITATIONS
SEARCH DETAIL
...